|
Conference Overview:
This conference is a gathering place for the leaders of the orphan drug sector to unite with big pharma and the investment community to address strategies in developing/commercializing orphan products and capitalize on the multibillion dollar market to treat rare diseases.
Audience Profile:
Biotech CEOs, Big/Specialty Pharma Executives, Clinicians/Researchers, Patient Advocacy Groups, Regulatory Experts along with Private and Public Market Investors
Program Information:
Craig Simak
Chief Strategic Officer
IBF*International Business Forum
Direct Phone & Fax (516) 307-0743
craig@ibfconferences.com
To register, please contact Cathy Fenn
IBF's Registrar
Direct Phone & Fax: (516) 882-5143
cathy@ibfconferences.com
|
